Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Condition

Caries

43

Unknown

2,596

Pain

619

Cancer

609

Hypertension

575

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

US Approved OTC

38

Possibly Marketed Outside US

5

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Methotrexate

38

Streptococcus mutans

38

T cell mediated immunity

38

Zinc transporter ZIP1

38

Zinc transporter ZIP2

38

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

43

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1921

38

Unknown

5

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

43

Preventing

40

Secondary

38

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

38

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Smithson, R.

38

Cherbuliez, E.|Weniger, H.

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

41

Mixture

1

Protein

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

43

CAS

42

PUBCHEM

42

EPA CompTox

40

MERCK INDEX

26

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

3

BLOOD AND BLOOD FORMING ORGANS

1

DERMATOLOGICALS

1

VARIOUS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

MINERAL SUPPLEMENTS

2

ALL OTHER THERAPEUTIC PRODUCTS

1

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS

1

MEDICATED DRESSINGS

1

OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER MINERAL SUPPLEMENTS

2

ALL OTHER THERAPEUTIC PRODUCTS

1

I.V. SOLUTION ADDITIVES

1

MEDICATED DRESSINGS

1

OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Zinc

2

Detoxifying agents for antineoplastic treatment

1

Electrolyte solutions

1

Various alimentary tract and metabolism products

1

Zinc bandages

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

40

Principal Form

3

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 43 results

First page disabled
Previous page disabled
1
Next page
Next page

ZINC CATION

13S1S8SF37

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

MAGNESIUM HEXAFLUOROSILICATE

H37V80D2JS

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Crystalline solid. Decomposes at 120°C. Contact may cause slight irritation to skin, eyes, and mucous membranes. May be slightly toxic by ingestion. Used to make other chemicals. Magnesium Hexafluorosilicate is used for mothproofing of textile fabric...

s. It has being used in the treatment of experimental caries of rats.

GLYCERYL 2-PHOSPHATE

WWH06G87W6

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Glycerol-2-phosphatase

Protein phosphatase

Alkaline phosphatase, tissue-nonspecific isozyme

Conditions:

Nutritional requirements

Uterine diseases

Intervertebral disc degradation

Sodium glycerol 2-phosphate (Disodium beta-glycerophosphate) is used for the preparation of thermo-sensitive chitosan hydrogen as a scaffold to construct tissue engineered injectable nucleus pulposus (NP). Since Sodium glycerol 2-phosphate (6 g/day) ...

reduced the lithogenic index of bile in human subjects with cholesterol gallstones in a short-term study and facilitated dissolution of cholesterol gallstones in mice, Sodium glycerol 2-phosphate may have potential to help dissolve cholesterol gallstones in man. Sodium glycerol 2-phosphate is an alkaline phosphate inhibitor. Sodium β-glycerophosphate pentahydrate is used as a phosphatase inhibitor. It promotes bone matrix mineralization while delivering to osteoblasts by providing a source of phosphate ions. It is used in the development of hydrogels and scaffolds, which finds applications in tissue engineering and cell growth. It is used as an additive in isolation mediums by providing phosphate ions to isolate. It is utilized to promote mineralization in vitro by modulating bone cell metabolic activity.

ZINC DIBUTYRATE

VA6XH8E3JX

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC CITRATE DIHYDRATE

021IBV57IL

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC SUCCINATE

IY01B595GR

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC OROTATE DIHYDRATE

2R18GO895S

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC MONOCARBONATE

K8290PTQ4F

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC NITRIDE

7OOJ6UE14L

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

AMMONIUM PENTACHLOROZINCATE

3ILV18PW3Y

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

Showing 1 - 10 of 43 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1